Publications by authors named "Guillermo Sanz"

100Publications

A case of megaloblastic anemia simulating a cold autoimmune hemolytic anemia.

Immunohematology 2020 Sep;36(3):89-92

Hematology and Transfusion Medicine Department, Hospital Universitari I Politècnic La Fe.

View Article

Download full-text PDF

Source
September 2020

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.

Nat Med 2020 Oct 3;26(10):1549-1556. Epub 2020 Aug 3.

Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41591-020-1008-zDOI Listing
October 2020

Are next-generation sequencing results knocking on Heaven's door for transplantation planning in chronic myelomonocytic leukemia?

Haematologica 2020 03;105(3):530-533

Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.240853DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049370PMC
March 2020

The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation.

J Infect 2020 Mar 20;80(3):333-341. Epub 2020 Jan 20.

Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, Madrid, Spain; Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jinf.2019.12.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112613PMC
March 2020

In MDS, is higher risk higher reward?

Authors:
Guillermo F Sanz

Hematology Am Soc Hematol Educ Program 2019 12;2019(1):381-390

Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain; and Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/hematology.2019000042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913486PMC
December 2019

Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?

Blood Adv 2019 11;3(21):3454-3460

Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019000680DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855105PMC
November 2019

Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.

Biol Blood Marrow Transplant 2020 02 23;26(2):358-366. Epub 2019 Oct 23.

Hematology Department, Hospital Universitari i Politecnic La Fe, Instituto de Investigación Sanitaria La Fe, Valencia, Spain; Centro de Investigación Biomédica en Red de Cancer, Instituto Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.10.014DOI Listing
February 2020

Noninfectious Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2019 09 24;25(9):1818-1824. Epub 2019 May 24.

Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.05.024DOI Listing
September 2019

Results of two protocols for platelet transfusion in patients undergoing abo incompatible hematopoietic stem cell transplantation.

Transfus Apher Sci 2019 04 19;58(2):185-186. Epub 2019 Mar 19.

CIBERONC, Instituto Carlos III, Madrid, Spain; Hospital Universitari i Politècnic La Fe, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transci.2019.02.002DOI Listing
April 2019

Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia.

J Infect 2019 05 21;78(5):393-401. Epub 2019 Feb 21.

Microbiology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain; Department of Microbiology, School of Medicine, University of Valencia, Av. Blasco Ibáñez 17, 46010 Valencia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jinf.2019.02.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126576PMC
May 2019

Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics.

J Mol Diagn 2019 03 19;21(2):228-240. Epub 2018 Dec 19.

Molecular Biology Unit, Clinical Pathology Service, La Fe University and Polytechnic Hospital, Valencia, Spain; La Fe Health Research Institute, Hematology Research Group, Valencia, Spain; CIBERONC, Carlos III Health Research Institute, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2018.09.009DOI Listing
March 2019

Current management of patients with chronic myelomonocytic leukemia.

Curr Opin Oncol 2018 11;30(6):409-417

Hospital Universitario y Politécnico La Fe, Valencia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000486DOI Listing
November 2018

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.

J Clin Oncol 2017 May 28;35(14):1591-1597. Epub 2017 Mar 28.

Sophie Park, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, Université Grenoble Alpes, Grenoble; Jean-François Hamel and Sylvain Thépot, CHU d'Angers; Sylvain Thépot, Université d'Angers, Institut National de la Santé et de la Recherche Médicale, Unité 1232, and LabEx IGO, Angers; Andrea Toma, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris-Est Créteil; Rosa Sapena and Pierre Fenaux, CHU Saint Louis, AP-HP, Université Paris X; François Dreyfus, CHU Cochin, AP-HP, Université Paris V, Paris; Charikleia Kelaidi, CHU Avicenne, Avicenne; Odile Beyne-Rauzy, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Agnès Guerci-Bresler, CHU Nancy, Nancy; Dominique Bordessoule, CHU Dupuytren, Limoges; Pascale Cony-Makhoul, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy; Stéphane Cheze, CHU de Caen, Caen; Eric Wattel, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon; Christian Rose, Université Catholique de Lille, Lille; Norbert Vey, Institut Paoli-Calmettes Marseille, Marseille, France; Maria Diez Campelo, Hospital Universitario de Salamanca, Salamanca; Teresa Bernal, Hospital Central de Asturias, Oviedo; Fernando Ramos, Hospital de León, León; Marisa Calabuig, Hospital Clínico de Valencia; Guillermo F. Sanz, Hospital Universitario y Politecnico La Fe, Valencia, Spain; Valeria Santini and Alessandro Sanna, Azienda Ospedaliero Universitaria (AOU) Careggi and University of Florence, Florence; Enrico Balleari, Istituto di Ricovero e Cura a Carattere Scientifico AOU San Martino di Genova, Genova; Daniela Gioia, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria; Dario Ferrero, Università degli Studi di Torino; Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Torino; Giovanni Cametti, Ospedale Maggiore di Chieri, Chieri; Fabrizio Pane, Università Federico II, Napoli, Italy; Mikkael A. Sekeres and Jaime Fensterl, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Rami Komrokji, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David P. Steensma, Dana-Farber Cancer Institute, Boston, MA; Gail J. Roboz, Weill Medical College of Cornell University, New York, NY; Jennifer Kaivers and Ulrich Germing, University of Düsseldorf, Düsseldorf; Katharina Götze and Catharina Müller-Thomas, Universität München, München, Germany; and Ioannis Kotsianidis, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3271DOI Listing
May 2017

A Lot to Learn about Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia.

Authors:
Guillermo F Sanz

Biol Blood Marrow Transplant 2017 05 9;23(5):713-714. Epub 2017 Mar 9.

Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.011DOI Listing
May 2017

Reply to M.A. Lichtman.

J Clin Oncol 2017 04 30;35(12):1376-1377. Epub 2017 Jan 30.

Leonor Arenillas and Xavier Calvo, Institut Hospital del Mar d'Investigacions Mèdiques, Hospital del Mar Research Institute, Barcelona, Spain; Guillermo F. Sanz, Hospital Universitario La Fe, Valencia, Spain; and Lourdes Florensa, Institut Hospital del Mar d'Investigacions Mèdiques, Hospital del Mar Research Institute, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3941DOI Listing
April 2017

Advances in haploidentical stem cell transplantation for hematologic malignancies.

Leuk Lymphoma 2016 08 13;57(8):1766-75. Epub 2016 Apr 13.

a Hematology Department , University Hospital La Fe and Department of Medicine, University of Valencia , Valencia , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1167204DOI Listing
August 2016

Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.

J Clin Oncol 2016 09 5;34(27):3284-92. Epub 2016 Jul 5.

Leonor Arenillas, Xavier Calvo, Carme Pedro, Ana Ferrer, and Lourdes Florensa, Hospital del Mar Research Institute; Esther Alonso, Hospital Universitario Bellvitge Hospitalet de Llobregat; Julia Montoro, Hospital Universitario Vall d' Hebron; Salut Brunet, Hospital Santa Creu i Sant Pau; Benet Nomdedeu, Hospital Clínic, Barcelona; Elisa Luño, Hospital Universitario Central Asturias, Oviedo; Leonor Senent and Guillermo F. Sanz, Hospital Universitario La Fe; Mar Tormo, Hospital Clínico Universitario de Valencia; Rafael Andreu, Hospital Universitario Doctor Peset, Valencia; Fernando Ramos, Hospital Universitario de León, León; María Teresa Ardanaz, Hospital Universitario Txagorritxu, Vitoria; Víctor Marco, Hospital Arnau Vilanova, Lleida; María Díez-Campelo, Hospital Universitario de Salamanca, Salamanca; Beatriz Arrizabalaga, Hospital Universitario Cruces, Baracaldo; Blanca Xicoy, ICO-Badalona, Badalona; Santiago Bonanad, Hospital La Ribera, Alzira; and Andrés Jerez, Hospital Morales Meseguer, IMIB-Arrixaca, Murcia, Spain.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.66.9705
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.66.9705DOI Listing
September 2016

One-unit versus two-unit cord-blood transplantation.

N Engl J Med 2015 01;372(3):287-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1414419DOI Listing
January 2015